Loss of fibulin-4 disrupts collagen synthesis and maturation: Implications for pathology resulting from EFEMP2 mutations

Christina L. Papke, Jun Tsunezumi, Léa Jeanne Ringuette, Hideaki Nagaoka, Masahiko Terajima, Yoshito Yamashiro, Greg Urquhart, Mitsuo Yamauchi, Elaine C. Davis, Hiromi Yanagisawa

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Homozygous recessive mutations in either EFEMP2 (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to autosomal recessive cutis laxa types 1B and 1A, respectively. Previously, fibulin-4was shown to bind lysyl oxidase (LOX), an elastin/collagen cross-linking enzyme, in vitro. Consistently, reported defects in humans with EFEMP2 mutations are more severe and broad in range than those due to FBLN5 mutations and encompass both elastin-rich and collagen-rich tissues. However, the underlying disease mechanism in EFEMP2 mutations has not been fully addressed. Here,we show that fibulin-4 is important for the integrity of aortic collagen in addition to elastin. Smooth muscle-specific Efemp2 loss in mouse (termed SMKO) resulted in altered fibrillar collagen localization with larger, poorly organized fibrils. LOX activity was decreased in Efemp2-null cells, and collagen cross-linking was diminished in SMKO aortas; however, elastin cross-linking was unaffected and the level of mature LOX was maintained to that of wild-type aortas. Proteomic screening identified multiple proteins involved in procollagen processing and maturation as potential fibulin-4-binding partners. We showed that fibulin-4 binds procollagen C-endopeptidase enhancer 1 (Pcolce), which enhances proteolytic cleavage of the procollagen C-terminal propeptide during procollagen processing. Interestingly, however, procollagen cleavage was not affected by the presence or absence of fibulin-4 in vitro. Thus, our data indicate that fibulin-4 serves as a potential scaffolding protein during collagen maturation in the extracellular space. Analysis of collagen in other tissues affected by fibulin-4 loss should further increase our understanding of underlying pathologic mechanisms in patients with EFEMP2 mutations.

Original languageEnglish (US)
Pages (from-to)5867-5879
Number of pages13
JournalHuman Molecular Genetics
Volume24
Issue number20
DOIs
StatePublished - Jun 5 2015

Fingerprint

Collagen
Procollagen
Pathology
Elastin
Protein-Lysine 6-Oxidase
Mutation
Aorta
Bone Morphogenetic Protein 1
Fibrillar Collagens
Null Lymphocytes
Extracellular Space
fibulin-4
Proteomics
Smooth Muscle
Proteins
Enzymes
Genes
In Vitro Techniques
fibulin

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Papke, C. L., Tsunezumi, J., Ringuette, L. J., Nagaoka, H., Terajima, M., Yamashiro, Y., ... Yanagisawa, H. (2015). Loss of fibulin-4 disrupts collagen synthesis and maturation: Implications for pathology resulting from EFEMP2 mutations. Human Molecular Genetics, 24(20), 5867-5879. https://doi.org/10.1093/hmg/ddv308

Loss of fibulin-4 disrupts collagen synthesis and maturation : Implications for pathology resulting from EFEMP2 mutations. / Papke, Christina L.; Tsunezumi, Jun; Ringuette, Léa Jeanne; Nagaoka, Hideaki; Terajima, Masahiko; Yamashiro, Yoshito; Urquhart, Greg; Yamauchi, Mitsuo; Davis, Elaine C.; Yanagisawa, Hiromi.

In: Human Molecular Genetics, Vol. 24, No. 20, 05.06.2015, p. 5867-5879.

Research output: Contribution to journalArticle

Papke, CL, Tsunezumi, J, Ringuette, LJ, Nagaoka, H, Terajima, M, Yamashiro, Y, Urquhart, G, Yamauchi, M, Davis, EC & Yanagisawa, H 2015, 'Loss of fibulin-4 disrupts collagen synthesis and maturation: Implications for pathology resulting from EFEMP2 mutations', Human Molecular Genetics, vol. 24, no. 20, pp. 5867-5879. https://doi.org/10.1093/hmg/ddv308
Papke, Christina L. ; Tsunezumi, Jun ; Ringuette, Léa Jeanne ; Nagaoka, Hideaki ; Terajima, Masahiko ; Yamashiro, Yoshito ; Urquhart, Greg ; Yamauchi, Mitsuo ; Davis, Elaine C. ; Yanagisawa, Hiromi. / Loss of fibulin-4 disrupts collagen synthesis and maturation : Implications for pathology resulting from EFEMP2 mutations. In: Human Molecular Genetics. 2015 ; Vol. 24, No. 20. pp. 5867-5879.
@article{8b4143c8e878493cb48217a986fe0d1a,
title = "Loss of fibulin-4 disrupts collagen synthesis and maturation: Implications for pathology resulting from EFEMP2 mutations",
abstract = "Homozygous recessive mutations in either EFEMP2 (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to autosomal recessive cutis laxa types 1B and 1A, respectively. Previously, fibulin-4was shown to bind lysyl oxidase (LOX), an elastin/collagen cross-linking enzyme, in vitro. Consistently, reported defects in humans with EFEMP2 mutations are more severe and broad in range than those due to FBLN5 mutations and encompass both elastin-rich and collagen-rich tissues. However, the underlying disease mechanism in EFEMP2 mutations has not been fully addressed. Here,we show that fibulin-4 is important for the integrity of aortic collagen in addition to elastin. Smooth muscle-specific Efemp2 loss in mouse (termed SMKO) resulted in altered fibrillar collagen localization with larger, poorly organized fibrils. LOX activity was decreased in Efemp2-null cells, and collagen cross-linking was diminished in SMKO aortas; however, elastin cross-linking was unaffected and the level of mature LOX was maintained to that of wild-type aortas. Proteomic screening identified multiple proteins involved in procollagen processing and maturation as potential fibulin-4-binding partners. We showed that fibulin-4 binds procollagen C-endopeptidase enhancer 1 (Pcolce), which enhances proteolytic cleavage of the procollagen C-terminal propeptide during procollagen processing. Interestingly, however, procollagen cleavage was not affected by the presence or absence of fibulin-4 in vitro. Thus, our data indicate that fibulin-4 serves as a potential scaffolding protein during collagen maturation in the extracellular space. Analysis of collagen in other tissues affected by fibulin-4 loss should further increase our understanding of underlying pathologic mechanisms in patients with EFEMP2 mutations.",
author = "Papke, {Christina L.} and Jun Tsunezumi and Ringuette, {L{\'e}a Jeanne} and Hideaki Nagaoka and Masahiko Terajima and Yoshito Yamashiro and Greg Urquhart and Mitsuo Yamauchi and Davis, {Elaine C.} and Hiromi Yanagisawa",
year = "2015",
month = "6",
day = "5",
doi = "10.1093/hmg/ddv308",
language = "English (US)",
volume = "24",
pages = "5867--5879",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "20",

}

TY - JOUR

T1 - Loss of fibulin-4 disrupts collagen synthesis and maturation

T2 - Implications for pathology resulting from EFEMP2 mutations

AU - Papke, Christina L.

AU - Tsunezumi, Jun

AU - Ringuette, Léa Jeanne

AU - Nagaoka, Hideaki

AU - Terajima, Masahiko

AU - Yamashiro, Yoshito

AU - Urquhart, Greg

AU - Yamauchi, Mitsuo

AU - Davis, Elaine C.

AU - Yanagisawa, Hiromi

PY - 2015/6/5

Y1 - 2015/6/5

N2 - Homozygous recessive mutations in either EFEMP2 (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to autosomal recessive cutis laxa types 1B and 1A, respectively. Previously, fibulin-4was shown to bind lysyl oxidase (LOX), an elastin/collagen cross-linking enzyme, in vitro. Consistently, reported defects in humans with EFEMP2 mutations are more severe and broad in range than those due to FBLN5 mutations and encompass both elastin-rich and collagen-rich tissues. However, the underlying disease mechanism in EFEMP2 mutations has not been fully addressed. Here,we show that fibulin-4 is important for the integrity of aortic collagen in addition to elastin. Smooth muscle-specific Efemp2 loss in mouse (termed SMKO) resulted in altered fibrillar collagen localization with larger, poorly organized fibrils. LOX activity was decreased in Efemp2-null cells, and collagen cross-linking was diminished in SMKO aortas; however, elastin cross-linking was unaffected and the level of mature LOX was maintained to that of wild-type aortas. Proteomic screening identified multiple proteins involved in procollagen processing and maturation as potential fibulin-4-binding partners. We showed that fibulin-4 binds procollagen C-endopeptidase enhancer 1 (Pcolce), which enhances proteolytic cleavage of the procollagen C-terminal propeptide during procollagen processing. Interestingly, however, procollagen cleavage was not affected by the presence or absence of fibulin-4 in vitro. Thus, our data indicate that fibulin-4 serves as a potential scaffolding protein during collagen maturation in the extracellular space. Analysis of collagen in other tissues affected by fibulin-4 loss should further increase our understanding of underlying pathologic mechanisms in patients with EFEMP2 mutations.

AB - Homozygous recessive mutations in either EFEMP2 (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to autosomal recessive cutis laxa types 1B and 1A, respectively. Previously, fibulin-4was shown to bind lysyl oxidase (LOX), an elastin/collagen cross-linking enzyme, in vitro. Consistently, reported defects in humans with EFEMP2 mutations are more severe and broad in range than those due to FBLN5 mutations and encompass both elastin-rich and collagen-rich tissues. However, the underlying disease mechanism in EFEMP2 mutations has not been fully addressed. Here,we show that fibulin-4 is important for the integrity of aortic collagen in addition to elastin. Smooth muscle-specific Efemp2 loss in mouse (termed SMKO) resulted in altered fibrillar collagen localization with larger, poorly organized fibrils. LOX activity was decreased in Efemp2-null cells, and collagen cross-linking was diminished in SMKO aortas; however, elastin cross-linking was unaffected and the level of mature LOX was maintained to that of wild-type aortas. Proteomic screening identified multiple proteins involved in procollagen processing and maturation as potential fibulin-4-binding partners. We showed that fibulin-4 binds procollagen C-endopeptidase enhancer 1 (Pcolce), which enhances proteolytic cleavage of the procollagen C-terminal propeptide during procollagen processing. Interestingly, however, procollagen cleavage was not affected by the presence or absence of fibulin-4 in vitro. Thus, our data indicate that fibulin-4 serves as a potential scaffolding protein during collagen maturation in the extracellular space. Analysis of collagen in other tissues affected by fibulin-4 loss should further increase our understanding of underlying pathologic mechanisms in patients with EFEMP2 mutations.

UR - http://www.scopus.com/inward/record.url?scp=84943763724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943763724&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddv308

DO - 10.1093/hmg/ddv308

M3 - Article

C2 - 26220971

AN - SCOPUS:84943763724

VL - 24

SP - 5867

EP - 5879

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 20

ER -